Skip to main content
. 2008 Apr 3;111(12):5477–5485. doi: 10.1182/blood-2008-01-132837

Figure 3.

Figure 3

EFS of NCI SR patients with favorable genetic features. (A) TEL-AML1. (B) Double trisomies. The very few patients with both lesions are included in panel A as a function of end-induction MRD. Outcome of MRD+ patients in both groups is much worse than those who are MRD. The 5-year EFS is indicated on each curve as appropriate.